New Zealand -
Ingliż -
Ministry for Primary Industries
artist
bayer new zealand limited - flufenacet; metribuzin - water dispersible granule - flufenacet 240 g/kg; metribuzin 175 g/kg - herbicide - herbicide
New Zealand -
Ingliż -
Ministry for Primary Industries
vimoy iblon
bayer new zealand limited - isoflucypram - emulsifiable concentrate (ec) - isoflucypram 50 g/litre - fungicide - fungicide
Singapor -
Ingliż -
HSA (Health Sciences Authority)
bayer ames minilet™ lancets
ascensia diabetes care singapore private limited - general hospital - bayer ames minilet™ lancets is intended for use with glucolet® 2 automatic lancing device to obtain blood for blood glucose testing.
New Zealand -
Ingliż -
Ministry for Primary Industries
vayego
bayer new zealand limited - tetraniliprole - suspension concentrate - tetraniliprole 200 g/litre - insecticide - insecticide
New Zealand -
Ingliż -
Ministry for Primary Industries
caley iblon
bayer new zealand limited - prothioconazole; isoflucypram - prothioconazole 100 g/litre; isoflucypram 50 g/litre - fungicide - fungicide
Irlanda -
Ingliż -
HPRA (Health Products Regulatory Authority)
bayer dog tasty bone 150/144/50 mg tablets
bayer animal health gmbh - febantel; pyrantel embonate ; praziquantel - tablet - 150,144,50 mg/tablet - febantel, combinations
Irlanda -
Ingliż -
HPRA (Health Products Regulatory Authority)
bayer dog tasty bone xl 525/504/175 mg tablets
bayer animal health gmbh - febantel; pyrantel embonate ; praziquantel - tablet - 525,504,175 mg/tablet - praziquantel, combinations
Ingilterra -
Ingliż -
VMD (Veterinary Medicines Directorate)
bayer praziquantel 50 mg tablets
bayer animal health gmbh - praziquantel - tablet - anthelmintic - cats, dogs
Unjoni Ewropea -
Ingliż -
EMA (European Medicines Agency)
eylea
bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - ophthalmologicals - eylea is indicated for adults for the treatment of:neovascular (wet) age-related macular degeneration (amd);visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo);visual impairment due to diabetic macular oedema (dme);visual impairment due to myopic choroidal neovascularisation (myopic cnv).